LUND,
Sweden, May 17, 2022 /PRNewswire/ -- The
Rhode Island Department of Health has granted Immunovia, Inc., the
US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), Clinical
Laboratory licensure, allowing physicians in Rhode Island to order the IMMray™ PanCan-d
test for their patients.
"Receiving licensure in Rhode
Island now allows us to offer IMMray™ PanCan-d in 46 states.
We expect additional state licensures to follow, as we work to make
IMMray™ PanCan-d accessible to patients across the United States who are at risk for
pancreatic cancer," says Jeff
Borcherding, Chief Executive Officer of Immunovia, Inc., the
US subsidiary of Immunovia AB.
For more information, please contact:
Philipp Mathieu
Acting CEO and President
Email: philipp.mathieu@immunovia.com
Tobias Bülow
Senior Director Investor Relations and Corporate Communications
Email: tobias.bulow@immunovia.com
Tel: +46 736 36 35 74
The information was submitted for publication on March 17, 2022, at 08:30
am CET.
About Immunovia
Immunovia AB is a diagnostic company with the vision to
revolutionize blood-based diagnostics and increase survival rates
for patients with cancer.
Our first product, IMMray™ PanCan-d is the only blood test
currently available specifically for the early detection of
pancreatic cancer. The test has unmatched clinical performance.
Commercialization of IMMray™ PanCan-d started in August 2021 in the USA and IMMray™ PanCan-d is offered as a
laboratory developed test (LDT) exclusively through Immunovia, Inc.
For more information see: www.immunoviainc.com.
Immunovia collaborates and engages with healthcare providers,
leading experts and patient advocacy groups globally to make this
test available to all high-risk pancreatic cancer groups.
The USA, the first market in
which IMMray™ PanCan-d is commercially available, is the world's
largest market for the detection of pancreatic cancer with an
estimated value of more than USD 4
billion annually.
Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm. For
more information, please visit www.immunovia.com.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/immunovia-ab/r/immunovia--inc--achieves-clinical-laboratory-licensure-from-rhode-island-dept-of-health-making-immra,c3567971
The following files are available for download:
|
https://mb.cision.com/Main/13121/3567971/1580408.pdf
|
Press release
(PDF)
|
View original
content:https://www.prnewswire.com/news-releases/immunovia-inc-achieves-clinical-laboratory-licensure-from-rhode-island-dept-of-health-making-immray-pancan-d-test-available-in-46-us-states-301548647.html
SOURCE Immunovia AB